Blue-Light Filtering Lenses Seem Not to Be Beneficial

WEDNESDAY, Aug. 23, 2023 (HealthDay News) -- Blue-light filtering lenses, which filter ultraviolet radiation and claim to improve visual performance with digital device use, seem not to attenuate symptoms of eye strain, according to a study published online Aug. 18 in the Cochrane Database of Systematic Reviews.
Sumeer Singh, Ph.D., from the University of Melbourne in Australia, and colleagues examined the effects of blue-light filtering lenses compared to non-blue-light filtering lenses in adults in a systematic review. A total of 17 randomized controlled trials (RCTs), with sample sizes ranging from five to 156 adult participants, were included. The primary outcomes were change in visual fatigue score and critical flicker-fusion frequency (CFF).
The researchers found that at less than one week of follow-up, there was no difference in subjective visual fatigue scores with blue-light filtering versus non-blue-light filtering lenses. In one RCT, there was no difference between the intervention arms, while two studies that measured visual fatigue scores showed no significant difference between intervention arms. CFF measured at less than one day of follow-up showed little to no difference with blue-light filtering versus non-blue-light filtering lenses. No significant difference between intervention arms was reported in one study, while another showed a less negative change in CFF (indicating less visual fatigue) with high- versus low-blue-light filtering lenses and non-blue-light filtering lenses.
"Our findings do not support the prescription of blue-light filtering lenses to the general population. These results are relevant to a broad range of stakeholders, including eye care professionals, patients, researchers and the broader community," senior author Laura E. Downie, Ph.D., from the University of Melbourne, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Related Posts
La pastilla para la COVID de Merck parece segura, pero podría plantear riesgos para el embarazo: FDA
LUNES, 29 de noviembre de 2021 (HealthDay News) -- La pastilla antiviral...
Un panel de los CDC respalda las vacunas contra el VSR para los adultos mayores
JUEVES, 22 de junio de 2023 (HealthDay News) -- Un panel asesor de los Centros...
Sexual, Gender Minorities With Chronic Skin Diseases More Likely to Face Barriers to Care
TUESDAY, Oct. 3, 2023 (HealthDay News) -- Sexual and gender-minority (SGM)...
Las terapias hormonales fomentan la salud mental de los jóvenes trans
JUEVES, 19 de enero de 2023 (HealthDay News) -- Mientras varios estados de EE....
